Quaker Capital Investments Lowers stake in Chemtura Corp (CHMT)

Chemtura Corp (CHMT) : Quaker Capital Investments reduced its stake in Chemtura Corp by 16.53% during the most recent quarter end. The investment management company now holds a total of 492,248 shares of Chemtura Corp which is valued at $15,028,331 after selling 97,488 shares in Chemtura Corp , the firm said in a disclosure report filed with the SEC on Aug 12, 2016.Chemtura Corp makes up approximately 5.63% of Quaker Capital Investments’s portfolio.

Other Hedge Funds, Including , Stevens Capital Management Lp reduced its stake in CHMT by selling 11,324 shares or 53.37% in the most recent quarter. The Hedge Fund company now holds 9,892 shares of CHMT which is valued at $302,003. Chemtura Corp makes up approx 0.01% of Stevens Capital Management Lp’s portfolio.Comerica Bank reduced its stake in CHMT by selling 760 shares or 2.92% in the most recent quarter. The Hedge Fund company now holds 25,282 shares of CHMT which is valued at $771,859. Chemtura Corp makes up approx 0.01% of Comerica Bank’s portfolio.Acrospire Investment Management reduced its stake in CHMT by selling 1,700 shares or 73.69% in the most recent quarter. The Hedge Fund company now holds 607 shares of CHMT which is valued at $17,330. Chemtura Corp makes up approx 0.01% of Acrospire Investment Management’s portfolio.Diam Ltd. reduced its stake in CHMT by selling 5,720 shares or 5.38% in the most recent quarter. The Hedge Fund company now holds 100,588 shares of CHMT which is valued at $2,856,699. Chemtura Corp makes up approx 0.04% of Diam Ltd.’s portfolio.

Chemtura Corp opened for trading at $30.2 and hit $30.24 on the upside on Monday, eventually ending the session at $29.94, with a gain of 0.81% or 0.24 points. The heightened volatility saw the trading volume jump to 4,19,691 shares. Company has a market cap of $1,892 M.

On the company’s financial health, Chemtura Corp reported $0.40 EPS for the quarter, missing the analyst consensus estimate by $ -0.06 based on the information available during the earnings call on Jul 28, 2016. Analyst had a consensus of $0.46. The company had revenue of $441.00 million for the quarter, compared to analysts expectations of $451.50 million. The company’s revenue was down -5.0 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.29 EPS.

Chemtura Corporation (Chemtura) is a global developer manufacturer and marketer of engineered industrial specialty chemicals. The Company’s products are sold to industrial manufacturing customers for use as additives ingredients or intermediates that add value to their end products. The Company operates in two segments: Industrial Performance Products and Industrial Engineered Products. Its Industrial Performance Products segment is a global manufacturer and marketer of lubricant additive components synthetic lubricant base-stocks synthetic finished fluids calcium sulfonate specialty greases and phosphate and polyester-based fluids and also engaged in the development and production of hot cast elastomer pre-polymers. Its Industrial Engineered Products segment is a global developer and manufacturer of bromine and bromine-based products and organometallic compounds. Its operations are located in North America Latin America Europe and Asia.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Chemtura Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on Chemtura Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.